Skip to main content
Have a personal or library account? Click to login
A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries Cover

A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries

Open Access
|Jul 2024

Figures & Tables

Table 1

Availability and affordability of polypills stocked in private pharmacies in Spain, India, Mauritius, and Argentina.

TYPEAVAILABILITY (%) INDICATIONMANUFACTURING COUNTRY AND COMPANYAFFORDABILITY
PUBLIC SECTORPRIVATE SECTORMEDIAN PRICE/TAB (USD)COST FOR 1 MONTH SUPPLY (USD)MINIMUM DAILY WAGE (USD)NUMBER OF DAYS’ WAGES
ArgentinaN = 1N = 3
Rosuvastatin + Candesartan + Hydrochlorothiazide0.0100.0Argentina (Lepetit)0.319.307.641.21
IndiaN = 5N = 5
Aspirin + Atorvastatin + Ramipril0.00.0*India (Zydus Lifesciences)0.041.265.410.23
Aspirin + Simvastatin + Ramipril + Atenolol + Hydrochlorothiazide0.00.0*India (Cadila)0.3410.141.87
Atorvastatin + Ramipril + Metoprolol0.00.0*India (Zydus Lifesciences, Emcure)0.134.040.75
Aspirin + Atorvastatin + Ramipril + Metoprolol0.00.0*India (Torrent, Zydus Lifesciences)0.123.600.67
Aspirin + Atorvastatin + Losartan0.00.0*India (Cipla)0.175.220.96
MauritiusN = 5N = 15
Atorvastatin + Perindopril + Amlodipine0.013.33France (Servier)0.8826.469.522.78
SpainN = 1N = 8
Aspirin + Atorvastatin + Ramipril0.0100.0Spain (Ferrer)0.7422.2032.660.68

[i] Polypills whose monthly supply cost more than one day’s wage of the lowest-paid government worker are provided in red.

*The medicine was physically out-of-stock on the survey day, but the pharmacist was able to provide price data as the medicine is usually stocked.

Table 2

Availability and affordability of two-pill combinations stocked in private pharmacies in six countries.

TYPEPUBLIC SECTOR AVAILABILITY (%)PRIVATE SECTOR AVAILABILITY (%)MANUFACTURING COMPANIESMEDIAN PRICE/TAB (USD)COST OF 1 MONTH SUPPLYLOWEST WAGE (USD)NUMBER OF DAYS’ WAGES
ArgentinaN = 1N = 3
Atorvastatin + Amlodipine0.0100.0Casaco laboratorios1.0030.007.643.93
BangladeshN = 3N = 5
Atorvastatin + Amlodipine0.071.4Delta Pharma, Beximco0.0732.190.464.76
CameroonN = 8N = 10
Atorvastatin + Amlodipine0.020.0Pfizer, Ajanta Pharma Limited0.4112.451.757.11
IndiaN = 5N = 5
Atorvastatin + Amlodipine0.040.0Torrent, Alembic0.113.355.410.62
Atorvastatin + Atenolol0.00.0*Numerous brands0.082.400.44
Atorvastatin + Losartan0.00.0*Numerous brands0.041.330.25
Atorvastatin + Metoprolol0.00.0*Numerous brands0.113.160.58
Atorvastatin + Olmesartan0.00.0*Numerous brands0.113.450.64
Atorvastatin + Ramipril0.020.0Sanofi India0.329.541.76
Atorvastatin +Telmisartan0.00.0*Numerous brands0.123.560.66
Rosuvastatin +Telmisartan0.00.0*Numerous brands0.185.401.00
NepalN = 5N = 5
Atorvastatin + Amlodipine0.00.0*Numerous brands0.123.514.420.79
SpainN = 1N = 8
Atorvastatin + Amlodipine0.0100.0Viatris Healthcare; Almirall S.A; Krka, d. d., Novo mesto0.501532.850.46
Rosuvastatin + Amlodipine0.0100.0Teva Pharmaceuticals0.501532.850.46

[i] *The medicine was physically out-of-stock on the survey day, but the pharmacist was able to provide price data as the medicine is usually stocked.

DOI: https://doi.org/10.5334/gh.1335 | Journal eISSN: 2211-8179
Language: English
Submitted on: Dec 16, 2023
Accepted on: Jun 10, 2024
Published on: Jul 1, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Gautam Satheesh, Bishal Gyawali, Marie France Chan Sun, Mark D. Huffman, Amitava Banerjee, Pablo Perel, Adrianna Murphy, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.